poisar

Stock

Adicet Bio, Inc. ACET

$8.22-0.48%

Overview

ACET market data

Price History

ACET price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$1.33
Diluted earnings per share over the trailing twelve months.
Beta
1.61
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-93.2%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$6.01 – $17.44
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $75.9M · P/B 0.51 · P/S 1.96.

Company News

3 captured
Guggenheim Maintains Buy on Adicet Bio, Lowers Price Target to $90Benzinga · Aug 6, 2026, 1:51 PM
Adicet Bio Q2 EPS $(1.99) Beats $(2.03) EstimateBenzinga · Aug 5, 2026, 10:08 PM
Lupus Nephritis Clinical Trial Landscape Becomes Increasingly Crowded with 30+ Pharma Companies | DelveInsightGlobenewswire Inc · Jun 10, 2026, 5:15 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock